Journals / İstanbul Tıp Fakültesi Dergisi / 2005 / Cilt: 68 - Sayı: 1

The relationship between height measurement and metabolic risk markers in overweight and obese women

Fazla kilolu ve şişman kadınlarda boy uzunluğunun risk göstergeleri ile ilişkisi

Pages
9–13
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Therefore, the measurement of metabolic risk markers could be useful in clinical screening for overweight and obese women of short stature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study was to determine the relationship between height and cardiovascular risk markers in overweight and obese women.
📊
Key Findings & Data:Materials and methods: The study group was composed of 3665 overweight or obese women with body mass index varying from 25 to 67 kg/m2.
💡
Conclusion & Impact:Therefore, the measurement of metabolic risk markers could be useful in clinical screening for overweight and obese women of short stature.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of this study was to determine the relationship between height and cardiovascular risk markers in overweight and obese women. Materials and methods: The study group was composed of 3665 overweight or obese women with body mass index varying from 25 to 67 kg/m2. In order to determine the relationship between body height and various cardiovascular risk markers, ANOVA, unpaired-t test and chi-square tests were performed. Results: Data analyses indicated a significant positive relationship between height and weight and HDL cholesterol and an inverse relationship between height and age, serum total cholesterol, glucose, triglyceride, systolic and diastolic blood pressure. No significant relationship was found between height and uric acid, insulin and HOMA (homeostasis model assessment). Age, weight, body mass index, glucose, cholesterol, triglyceride, systolic and diastolic blood pressures were found to vary between quartiles of stature. The incidence of diabetes mellitus, hypertension, hypercholesterolemia and abdominal obesity also was found to differ significantly between quartiles of stature using ANOVA analysis. Conclusion: These results support the suggestion that short stature may be relevant to hyperglycemia, hypertension and hypercholesterolemia. Therefore, the measurement of metabolic risk markers could be useful in clinical screening for overweight and obese women of short stature.

Özet

Amaç: Kısa boy bazı kardiyovasküler risk faktörleri ile ilişki göstermektedir. Bu çalışma fazla kilolu ve şişman kadınlarda boy uzunluğu ile çeşitli kardiyovasküler risk faktörleri arasındaki ilişkiyi araştırmak amacıyla gerçekleştirildi. Gereç ve yöntem: Beden kitle indeksi 25-67 kg/m2 arasında değişen 3665 fazla kilolu ve şişman kadında boy ile serum glukoz, ürik asit, total ve HDL-kolesterol, trigliserit, insülin, HOMA (homeostasis model assessment), sistolik ve diyastolik damar basıncı arasındaki ilişki, korelasyon analizi ve boy uzunluğuna göre ayrılmış dört grupta ANOVA, eşlenmemiş seri t-testi ve ki-kare testi ile araştırıldı. Bulgular: Olgularda boy uzunluğu ile ağırlık ve HDL kolesterol arasında anlamlı pozitif, boy uzunluğu ile yaş, beden kitle indeksi, glukoz, kolesterol, trigliserit, maksimum ve minimum damar basıncı ve bel-kalça oranı arasında anlamlı negatif ilişkiler bulundu. Boy ile ürik asit, insülin ve HOMA arasında anlamlı bir ilişki saptanmadı. Boy uzunluğuna göre dört gruba ayrılan olgularda ANOVA ile yaş, ağırlık, beden kitle indeksi, glukoz, maksimum ve minimum damar basıncı, kolesterol, trigliserit ve bel kalça oranı açısından gruplararası anlamlı farklar bulundu. Vakalarda çeyrek gruplar arasında diabetes mellitus, hipertansiyon, hiperkolesterolemi ve abdominal şişmanlık varlığı bakımından anlamlı farklılık bulundu. Aksine hipertrigliseridemi ve HDL-kolesterol düşüklüğü varlığı açısından anlamlı bir fark saptanmadı. Sonuç: Bulgularımız, fazla kilolu ve şişman kadınlarda kısa boyun hiperglisemi, hipertansiyon ve hiperkolesterolemi gibi tablolar birlikte olabileceğini desteklemektedir. Bu nedenle kısa boylu ve fazla kilolu veya şişman olan kadınlar kardiyovasküler risk varlığı bakımından daha yakından izlenmelidir.

🔖

Cite This Article

SERTKAYA, Ç. A., AKKAYA, V., ÖZBEY, N., ORHAN, Y. (2022). The relationship between height measurement and metabolic risk markers in overweight and obese women. İstanbul Tıp Fakültesi Dergisi, Cilt: 68 - Sayı: 1, 9–13. https://ajindex.com/articles/652077

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Anastasiou E, Alevizaki M, Grigorakis SJ, Philippou G, Kyprianou M, Souvatzoglou A. Decreased stature in gestational diabetes mellitus. Diabetologia 1998; 41: 997 – 1001
  2. Armitage P, Berry G. Statistical Methods in Medical Research, Blackwell, Oxford, 2.Baskı, 1987
  3. Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K, Clark PM. Type 2 (non-insulin dependent) diabetes mellitus, hypertension and hyperlipidemia (syndrome X). Relation to reduced fetal growth. Diabetologia 1993; 36: 62-67
  4. Branchtein L, Schmidt MI, Matos MC, Yamashita T, Pousada JM, Duncan BB. Short stature and gestational diabetes in Brazil.:Brazilian Gestational Diabetes Study Group. Diabetologia 2000; 43: 848-851
  5. D’Avanzo B, La Vecchia C, Negri E: Height and the risk of acute myocardial infarction in Italian women. Soc Sci Med 1994; 38: 193-196
  6. Davey-Smith G, Hart C, Upton M, Hole D, Gillis C, Watt G, Hawthorne V. Height and risk of death among men and women. Aetiological implications of associations with cardiorespiratory disease and cancer mortality. J Epidemiol Commun Health 2000; 54: 97-103
  7. Despres JP, Prud’homme D, Pouliot MC, Tremblay A, Bouchard C. Estimation of deep abdominal adipose tissue accumulation from simple anthropometric measurements in men. Am J Clin Nutr 1991; 54: 471-477
  8. Forsen T, Eriksson J, Qiao Q, Tervahauta M, Nissinen A, Tuomilehto J. Short stature and coronary heart disease. A 35 year follow up of the Finnish cohorts of the seven countries study. J Intern Med 2000; 248: 326-332
  9. Haffner SM, Stern MP, Hazuda HP, Pugh J, Patterson JK. Do upper body and centralized adiposity measure different aspects of regional body fat distribution? Relationship to non-insulin dependent diabetes mellitus, lipids and lipoproteins. Diabetes 1987; 36: 43-51
  10. Han TS, Feskens EJ, Lean ME, Seidell JC. Associations of body composition with type 2 diabetes mellitus. Diabet Med 1998; 15: 129-135
  11. Houmard JA, Wheeler WS, McCammon MR, Well JM, Truitt N, Hamad SF, Holbert D, Israel RG, Barakat HA. An evaluation of waist to hip ratio measurement methods in relation to lipid and carbonhydrate metabolism in men. Int J Obes 1991; 15: 181- 188
  12. Hsieh SD, Yoshinaga H. Do people with similar waist circumference share similar health risks irrespective of height? Tohoku J Exp Med 1999; 188: 55-60
  13. Hsieh SD, Yoshinaga H, Muto T. Waist to height ratio. Asimple and practical index for assesing central fat distribution and metabolic risk in Japanese men and women.